MRVL vs PFE: Which Is the Better Buy?
Side-by-side comparison of Marvell Technology, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Marvell Technology, Inc. · Technology
$133.37
+23.0% upside to fair value
High Conviction
Grade B
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRVL |
PFE |
| Current Price |
$133.37 |
$26.33 |
| Fair Value Estimate |
$164.02 |
$33.85 |
| Upside to Fair Value |
+23.0%
|
+28.6%
|
| Market Cap |
$116.6B |
$149.8B |
| Forward P/E |
42.4x
|
19.3x
|
| EV / EBITDA |
—
|
12.9x
|
| Price / Sales |
14.2x
|
2.4x
|
| Price / FCF |
83.7x
|
16.5x
|
| Revenue Growth YoY |
+7.0%
|
-1.2%
|
| Gross Margin |
50.1%
|
70.3%
|
| Operating Margin |
16.3%
|
24.7%
|
| Return on Equity |
19.4%
|
8.7%
|
| Dividend Yield |
— |
0% |
| FCF Yield |
1.2%
|
6.06%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
MRVL |
PFE |
| Zone Low |
$123.02 |
$25.39 |
| Zone High |
$139.42 |
$28.77 |
| In Buy Zone? |
Yes
|
Yes
|